BB Bioventures leads $44m investment in Novirio
BB Bioventures has led the third round of funding for the pharmaceutical company, which will use the money to develop drugs against hepatitis B and C.
BB Bioventures has led the third round of funding for the pharmaceutical company, which will use the money to develop drugs against hepatitis B and C.
Copyright PEI Media
Not for publication, email or dissemination